In recent weeks, the European market has shown signs of resilience, with the pan-European STOXX Europe 600 Index ending higher and hopes of increased government spending providing a boost despite ongoing concerns about U.S. tariffs. Amid this environment of mixed economic signals and cautious central bank policies, investors may find opportunities in stocks that are trading below their intrinsic value, as these can potentially offer attractive returns when market conditions stabilize.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Biotage (OM:BIOT) | SEK98.00 | SEK191.12 | 48.7% |
Absolent Air Care Group (OM:ABSO) | SEK256.00 | SEK508.82 | 49.7% |
Romsdal Sparebank (OB:ROMSB) | NOK130.70 | NOK258.18 | 49.4% |
Somec (BIT:SOM) | €10.50 | €20.55 | 48.9% |
TF Bank (OM:TFBANK) | SEK349.00 | SEK685.43 | 49.1% |
dormakaba Holding (SWX:DOKA) | CHF684.00 | CHF1352.22 | 49.4% |
F-Secure Oyj (HLSE:FSECURE) | €1.754 | €3.45 | 49.1% |
Carasent (OM:CARA) | SEK20.815 | SEK40.71 | 48.9% |
Dino Polska (WSE:DNP) | PLN445.20 | PLN887.95 | 49.9% |
Fodelia Oyj (HLSE:FODELIA) | €7.14 | €13.91 | 48.7% |
Click here to see the full list of 201 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Underneath we present a selection of stocks filtered out by our screen.
Overview: Exail Technologies offers robotics, maritime, navigation, aerospace, and photonics technology solutions in France and internationally with a market cap of €677.20 million.
Operations: The company's revenue is primarily derived from its Navigation & Maritime Robotics segment, which contributes €252.35 million, and its Advanced Technologies segment, which adds €87.52 million.
Estimated Discount To Fair Value: 38.6%
Exail Technologies is trading at €39.85, significantly undervalued compared to its estimated fair value of €64.86, suggesting a potential opportunity for investors focused on cash flow valuation. The company is expected to achieve profitability within three years, with earnings projected to grow 80.75% annually, outpacing the average market growth in France. However, investors should consider the stock's high volatility over the past three months when assessing risk.
Overview: Thales S.A. operates globally, offering solutions in defence and security, aerospace and space, digital identity and security, and transport markets with a market cap of €51.53 billion.
Operations: The company's revenue is primarily derived from its Defence segment at €11.32 billion, followed by Aerospace at €5.64 billion, and Cyber & Digital at €4.15 billion.
Estimated Discount To Fair Value: 11.6%
Thales, trading at €251, is slightly undervalued compared to its estimated fair value of €284.05. The company's earnings are projected to grow 17.2% annually, surpassing the French market's growth rate of 13%. Recent strategic collaborations in IoT and a focus on M&A could enhance its cash flow potential. However, revenue growth forecasts remain modest at 6.9% annually, indicating limited upside in terms of significant undervaluation based on cash flows alone.
Overview: Synektik Spólka Akcyjna operates in Poland, offering products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications with a market cap of PLN1.81 billion.
Operations: Synektik Spólka Akcyjna generates revenue through its offerings in surgery, diagnostic imaging, and nuclear medicine applications within Poland.
Estimated Discount To Fair Value: 34.9%
Synektik Spólka Akcyjna, trading at PLN 212, is significantly undervalued compared to its estimated fair value of PLN 325.84. Despite a recent decline in quarterly revenue to PLN 203.13 million from PLN 271.3 million, the company's earnings grew by over 22% last year and are forecasted to grow annually by 15.6%, outpacing the Polish market's growth rate of 12.8%. This suggests potential for strong cash flow generation despite slower revenue growth forecasts at 8.7% annually.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ENXTPA:EXA ENXTPA:HO and WSE:SNT.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。